Skip to main content

Table 4 Cytotoxicity of L-OHP on OCUM-2MD3/L-OHP (μg/mL, %, x ¯ ± s, 48 h).

From: Anti-tumor effects of CIK combined with oxaliplatin in human oxaliplatin-resistant gastric cancer cells in vivo and in vitro

Group

600

300

150

75

37.5

IC50

OCUM-2MD3

85.2 ± 0.9

74.6 ± 1.7

65.4 ± 2.1

51.2 ± 1.4

37.3 ± 2.2

71.2

OCUM-2MD3/L-OHP

72.4 ± 1.5*

52.7 ± 2.6*

43.5 ± 0.8*

26.4 ± 1.5*

9.8 ± 3.2*

235.2

  1. *Compared with OCUM-2MD3 Group P < 0.05
Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us